Picture [iito] Made Without Love 650x80px
Document › Details

Orphazyme A/S. (2/7/20). "Press Release: Orphazyme Completes Offering of 7,032,937 Shares in a Directed Issue and Private Placement and Raises approximately DKK 745,000,000 (EUR 100 Million / USD 110 Million) [Not for US, CA, JP or AU]". Copenhagen.

Organisations Organisation Orphazyme A/S (Nasdaq Copenhagen: ORPHA.CO)
  Group Orphazyme (Group)
  Organisation 2 Novo Holdings A/S
  Group Novo Group (Group)
Products Product arimoclomol
  Product 2 investment banking
Index term Index term Orphazyme–SEVERAL: investment, 202002 directed issue + private placement DKK745m (€100m) of 7m new + existing shares
Persons Person Stratton, Kim (Orphazyme 202002 CEO)
  Person 2 Vadsholt, Anders (TopoTarget 201011 CFO)

Record changed: 2020-02-12


Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Orphazyme (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture [iito] Back into Ad 650x80px

» top